With winter approaching, it's important to protect infants from RSV, which is very harmful to the very young. A safe and effective vaccine is available for pregnant women and newborns. Learn more: Maternal #RSV vaccination and nirsevimab reduced RSV associated hospitalizations among US infants in 20242025 by up to 51%. Both interventions demonstrated high effectiveness and durability in real world surveillance. https: ja.ma 4saoasz Monoclonal Antibody Prophylaxis for Infectious Diseases Mabion Le 18 septembre, l'Agence europenne du mdicament (EMA) a donn son feu vert la commercialisation d'Enflonsia (clesrovimab, MSD), un nouvel anticorps monoclonal destin la prvention des infections des voies respiratoires Coronavirus. La piste des anticorps monoclonaux pour lutter contre le Covid 19